FenebrutinibRMSCOVID-19UTIpharyngitisNCT05119569MSOLE
…results through Week 48, during which all participants received Fenebrutinib 200 mg BID.Results 99 participants enrolled in the OLE; and 96 …
1articles mentioning drugs
6drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: Fenebrutinib ×
Fenebrutinib
This drug is selected. Its supporting articles are shown below.